Manufacturer record
Tanpal Pharmaceuticals: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
6 batches manufactured by Tanpal Pharmaceuticals (Punjab) were declared Not of Standard Quality between December 2019 and January 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
6 records linked to Tanpal Pharmaceuticals in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ramipril Tablets IP 5 mg | TPT- 0102040Mfg ? · Exp ? | Assay of RamiprilAssay | RDTL ChandigarhCDSCO lab | Jan 2025 |
| Pyridoxine Tablets IP 10 mg (Pyrotan-10) | TPT- 0102064Mfg ? · Exp ? | Assay of PyridoxineAssay | RDTL ChandigarhCDSCO lab | Jan 2025 |
| Clobazam Tablets IP 5 mg | TPT-012058Mfg 2024-01 · Exp 2026-12 | DissolutionDissolution | CDL KolkataCDSCO lab | Jan 2025 |
| Zolpidem Tartrate E.R. Tablets IP 12.5 mg (SOO FRESH-CR-12.5 TABLETS) | TPT-0627Mfg 2021-06 · Exp 2023-05 | DissolutionDissolution | RDTL ChandigarhState lab | Mar 2022 |
| Sertraline Hydrochloride Tablets IP 50 mg (SERTOMAX-50 TABLETS) | TPT-01014Mfg 2021-03 · Exp 2023-02 | DissolutionDissolution | RDTL ChandigarhState lab | Feb 2022 |
| Rebeprazole Sodium Tablets I.P. (YDZOLE 20) | TPT-0203Mfg 2018-10 · Exp 2020-09 | DissolutionDissolution | RDTL GuwahatiState lab | Dec 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.